+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

New alternatives in the N.H.S. II. What advances in treatment can we afford? Can we afford centres of academic excellence?



New alternatives in the N.H.S. II. What advances in treatment can we afford? Can we afford centres of academic excellence?



British Medical Journal 4(5940): 328




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 043738238

Download citation: RISBibTeXText

PMID: 4434091

DOI: 10.1136/bmj.4.5940.328


Related references

Academic health centres: can we afford to fund them? Can we afford not to?. Leadership in Health Services 5(6): 11-3 29, 1996

New alternatives in the N.H.S. II. What advances in treatment can we afford? Criteria for introducing technical advance. British Medical Journal 4(5940): 327-333, 1974

New alternatives in the N.H.S. II. What advances in treatment can we afford? The customer's voice in determining medicoeconomic priorities. British Medical Journal 4(5940): 328-329, 1974

To afford or not to afford: A new formalization of affordances toward affordance-based robot control. Adaptive Behavior 15(4): 447-472, 2007

Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?. Journal of Gastroenterology and Hepatology 24(7): 1160-1162, 2009

Providing outpatient prescription drugs through Medicare: can we afford to? Can we afford not to?. Issue Brief 1999(736): 1-3, 1999

Oral healthcare for older people: 'I can't afford not to go to the dentist, but can I afford it?'. New Zealand Medical Journal 121(1281): 72-79, 2008

New advances in the N.H.S. II. What advances in treatment can we afford? What information do doctors need?. British Medical Journal 4(5940): 329, 1974

Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?). Circulation 104(13): 1564-1570, 2001

Serum theophylline and phenytoin levels: can we afford to do them? Can we afford not to?. Annals of Emergency Medicine 15(3): 344-348, 1986

Task force 2: The cost of prevention: Can we afford it? Can we afford not to do it?. Journal of the American College of Cardiology 40(4): 603-615, 2002

Single donor platelets: Can we afford to use them? Can we afford not to use them?. Transfusion Science 18(4): 585-588, 1997

Can we afford to eliminate restenosis? Can we afford not to?. Journal of the American College of Cardiology 43(4): 513-518, 2004

Darzi centres: an expensive luxury the UK can no longer afford?. Bmj 341: C6287, 2010

Can U.S. Cities Afford Living Wage Programs? An Examination of Alternatives. Review of Radical Political Economics 31(1): 16-53, 1999